Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $4.79 Consensus PT from Brokerages
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are presently covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong […]
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are presently covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong […]
